CD14 and melanoma: Table 3 shows the results for these three datasets. It is evident from the table that the cell type with the small number of samples (such as pDCs and DC for CBMC, NK and Treg cells for Melanoma, and dendritic, CD34+, CD14+ cells, and monocytes for PBMC68k) proposed a method that outperformed the other models in terms of correct predictions.